U.S. court upholds patents on Pfizer's cancer drug
October 23, 2014 at 08:57 AM EDT
Oct 23 (Reuters) - A U.S. district court ruled in favor of Pfizer Inc in a patent lawsuit it filed against Mylan Inc alleging patent infringement on its cancer drug, Sutent, Pfizer said.